Whitney Ijem

Stock Analyst at Canaccord Genuity

(4.50)
# 283
Out of 5,044 analysts
108
Total ratings
52.69%
Success rate
24.39%
Average return

Stocks Rated by Whitney Ijem

Palvella Therapeutics
Oct 9, 2025
Maintains: Buy
Price Target: $66$90
Current: $73.50
Upside: +22.45%
Generation Bio Co.
Aug 18, 2025
Maintains: Buy
Price Target: $9$10
Current: $5.80
Upside: +72.56%
Passage Bio
Aug 14, 2025
Maintains: Buy
Price Target: $260$67
Current: $7.66
Upside: +774.67%
Fractyl Health
Aug 14, 2025
Maintains: Buy
Price Target: $12$6
Current: $1.28
Upside: +368.75%
Taysha Gene Therapies
Aug 13, 2025
Maintains: Buy
Price Target: $11$14
Current: $4.99
Upside: +180.56%
Ultragenyx Pharmaceutical
Aug 8, 2025
Maintains: Buy
Price Target: $136$128
Current: $34.77
Upside: +268.13%
Vertex Pharmaceuticals
Aug 6, 2025
Maintains: Hold
Price Target: $424$411
Current: $422.39
Upside: -2.70%
Wave Life Sciences
Aug 4, 2025
Initiates: Buy
Price Target: $19
Current: $7.59
Upside: +150.33%
Alnylam Pharmaceuticals
Aug 1, 2025
Maintains: Buy
Price Target: $390$415
Current: $475.91
Upside: -12.80%
Rocket Pharmaceuticals
Jul 25, 2025
Maintains: Buy
Price Target: $11$10
Current: $3.97
Upside: +151.89%
Maintains: Buy
Price Target: $92$105
Current: $113.46
Upside: -7.46%
Maintains: Buy
Price Target: $74$54
Current: $13.96
Upside: +286.82%
Maintains: Buy
Price Target: $68$66
Current: $9.88
Upside: +568.02%
Maintains: Buy
Price Target: $18$6
Current: $1.56
Upside: +284.62%
Maintains: Buy
Price Target: $148$150
Current: $24.22
Upside: +519.32%
Maintains: Hold
Price Target: $93$84
Current: $53.49
Upside: +57.04%
Downgrades: Neutral
Price Target: n/a
Current: $117.88
Upside: -
Upgrades: Overweight
Price Target: $120$240
Current: $6.33
Upside: +3,691.47%